{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T18:12:59Z","timestamp":1778350379958,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/j.vaccine.2014.08.022","type":"journal-article","created":{"date-parts":[[2014,8,20]],"date-time":"2014-08-20T05:16:06Z","timestamp":1408511766000},"page":"5696-5702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis"],"prefix":"10.1016","volume":"32","author":[{"given":"Frank","family":"von Sonnenburg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Perona","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ulf","family":"Darsow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johannes","family":"Ring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1945-178X","authenticated-orcid":false,"given":"Alfred","family":"von Krempelhuber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jens","family":"Vollmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6206-091X","authenticated-orcid":false,"given":"Siegfried","family":"Roesch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Baedeker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herwig","family":"Kollaritsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"April (3)","key":"10.1016\/j.vaccine.2014.08.022_bib0005","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1001\/jama.1970.03170160031005","article-title":"Deaths attributable to smallpox vaccination, 1959 to 1966, and 1968","volume":"212","author":"Lane","year":"1970","journal-title":"JAMA"},{"key":"10.1016\/j.vaccine.2014.08.022_bib0010","series-title":"Smallpox and its eradication","author":"Fenner","year":"1988"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2014.08.022_bib0015","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1067\/mai.2002.128052","article-title":"Smallpox vaccination: risk considerations for patients with atopic dermatitis","volume":"110","author":"Engler","year":"2002","journal-title":"J Allergy Clin Immunol"},{"issue":"July (2)","key":"10.1016\/j.vaccine.2014.08.022_bib0020","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1086\/375825","article-title":"Smallpox vaccination: a review, part II. Adverse events","volume":"37","author":"Fulginiti","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"March (3)","key":"10.1016\/j.vaccine.2014.08.022_bib0025","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.immuni.2006.02.006","article-title":"Cytokine milieu of atopic dermatitis skin subverts the innate immune response to vaccinia virus","volume":"24","author":"Howell","year":"2006","journal-title":"Immunity"},{"issue":"January (9352)","key":"10.1016\/j.vaccine.2014.08.022_bib0030","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/S0140-6736(03)12193-9","article-title":"Atopic dermatitis","volume":"361","author":"Leung","year":"2003","journal-title":"Lancet"},{"issue":"April (4)","key":"10.1016\/j.vaccine.2014.08.022_bib0035","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1093\/oxfordjournals.aje.a121252","article-title":"Risks of smallpox vaccination complications in the United States","volume":"93","author":"Lane","year":"1971","journal-title":"Am J Epidemiol"},{"issue":"May (3)","key":"10.1016\/j.vaccine.2014.08.022_bib0040","first-page":"435","article-title":"Widespread eczema vaccinatum acquired by contacts. A report of an autopsy case","volume":"29","author":"Shirasawa","year":"1979","journal-title":"Acta Pathol Jpn"},{"issue":"December (6)","key":"10.1016\/j.vaccine.2014.08.022_bib0045","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1016\/j.jaci.2007.08.004","article-title":"Impaired immune response to vaccinia virus inoculated at the site of cutaneous allergic inflammation","volume":"120","author":"Scott","year":"2007","journal-title":"J Allergy Clin Immunol"},{"issue":"June (RR-10)","key":"10.1016\/j.vaccine.2014.08.022_bib0050","first-page":"1","article-title":"Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001","volume":"50","author":"Rotz","year":"2001","journal-title":"MMWR Recomm Rep"},{"issue":"October (15)","key":"10.1016\/j.vaccine.2014.08.022_bib0055","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1001\/jama.288.15.1901","article-title":"Contact vaccinia \u2013 transmission of vaccinia from smallpox vaccination","volume":"288","author":"Neff","year":"2002","journal-title":"JAMA"},{"issue":"March (2)","key":"10.1016\/j.vaccine.2014.08.022_bib0060","first-page":"84","article-title":"Expected adverse events in a mass smallpox vaccination campaign","volume":"5","author":"Kemper","year":"2002","journal-title":"Eff Clin Pract"},{"key":"10.1016\/j.vaccine.2014.08.022_bib0065","series-title":"ADVN atopic dermatitis and vaccinia network","author":"National Jewish Health","year":"2010"},{"issue":"November (47)","key":"10.1016\/j.vaccine.2014.08.022_bib0070","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.1055\/s-0028-1108143","article-title":"MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl.)","volume":"99","author":"Stickl","year":"1974","journal-title":"Dtsch Med Wochenschr"},{"issue":"December (5\u20136)","key":"10.1016\/j.vaccine.2014.08.022_bib0075","first-page":"375","article-title":"The smallpox vaccination strain MVA: marker, genetic structure, experience gained with the parenteral vaccination and behavior in organisms with a debilitated defence mechanism (author's transl.)","volume":"167","author":"Mayr","year":"1978","journal-title":"Zentralbl Bakteriol [B]"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.022_bib0080","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/BF01641272","article-title":"Passage history, properties, and use of attenuated vaccinia virus strain MVA","volume":"3","author":"Mayr","year":"1975","journal-title":"Infection"},{"issue":"March (12)","key":"10.1016\/j.vaccine.2014.08.022_bib0085","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.vaccine.2005.11.022","article-title":"Safety and immunogenicity of IMVAMUNE, a promising candidate as a third generation smallpox vaccine","volume":"24","author":"Vollmar","year":"2006","journal-title":"Vaccine"},{"issue":"December (51)","key":"10.1016\/j.vaccine.2014.08.022_bib0090","doi-asserted-by":"publisher","first-page":"8562","DOI":"10.1016\/j.vaccine.2007.10.017","article-title":"Clinical and immunologic responses to multiple doses of IMVAMUNE (modified vaccinia Ankara) followed by Dryvax challenge","volume":"25","author":"Frey","year":"2007","journal-title":"Vaccine"},{"issue":"February (5)","key":"10.1016\/j.vaccine.2014.08.022_bib0095","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1016\/j.vaccine.2009.11.030","article-title":"A randomized, double-blind, dose-finding Phase II study to evaluate immunogenicity and safety of the third generation smallpox vaccine candidate IMVAMUNE","volume":"28","author":"von Krempelhuber","year":"2010","journal-title":"Vaccine"},{"issue":"June (12)","key":"10.1016\/j.vaccine.2014.08.022_bib0100","doi-asserted-by":"publisher","first-page":"7845","DOI":"10.1128\/JVI.79.12.7845-7851.2005","article-title":"Modified vaccinia virus Ankara protects macaques against respiratory challenge with monkeypox virus","volume":"79","author":"Stittelaar","year":"2005","journal-title":"J Virol"},{"issue":"March (6979)","key":"10.1016\/j.vaccine.2014.08.022_bib0105","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox","volume":"428","author":"Earl","year":"2004","journal-title":"Nature"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2014.08.022_bib0110","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1172\/JCI33940","article-title":"Survival of lethal poxvirus infection in mice depends on TLR9, and therapeutic vaccination provides protection","volume":"118","author":"Samuelsson","year":"2008","journal-title":"J Clin Invest"},{"issue":"August (31)","key":"10.1016\/j.vaccine.2014.08.022_bib0115","doi-asserted-by":"publisher","first-page":"10889","DOI":"10.1073\/pnas.0804985105","article-title":"Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus","volume":"105","author":"Earl","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"August","key":"10.1016\/j.vaccine.2014.08.022_bib0120","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.1099\/vir.0.010553-0","article-title":"Evaluation of smallpox vaccines using variola neutralization","volume":"90","author":"Damon","year":"2009","journal-title":"J Gen Virol"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2014.08.022_bib0130","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/j.jacc.2003.11.053","article-title":"Smallpox vaccination and myopericarditis: a clinical review","volume":"43","author":"Cassimatis","year":"2004","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.vaccine.2014.08.022_bib0135","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1159\/000245677","article-title":"Clinical validation and guidelines for the SCORAD index: consensus report of the European Task Force on Atopic Dermatitis","volume":"195","author":"Kunz","year":"1997","journal-title":"Dermatology"},{"key":"10.1016\/j.vaccine.2014.08.022_bib0145","series-title":"International conference of emerging infectious diseases","article-title":"Clinical experience with a smallpox vaccine in populations with contraindications for vaccination with Dryax","author":"Vollmar","year":"2006"},{"issue":"June (9580)","key":"10.1016\/j.vaccine.2014.08.022_bib0150","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","article-title":"Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2014.08.022_bib0155","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1586\/14760584.8.1.13","article-title":"IMVAMUNE: modified vaccinia Ankara strain as an attenuated smallpox vaccine","volume":"8","author":"Kennedy","year":"2009","journal-title":"Expert Rev Vaccines"},{"issue":"April (17)","key":"10.1016\/j.vaccine.2014.08.022_bib0160","doi-asserted-by":"publisher","first-page":"1265","DOI":"10.1056\/NEJMoa020534","article-title":"Clinical responses to undiluted and diluted smallpox vaccine","volume":"346","author":"Frey","year":"2002","journal-title":"N Engl J Med"},{"issue":"April (1\u20132)","key":"10.1016\/j.vaccine.2014.08.022_bib0165","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jim.2007.02.003","article-title":"Defining blood processing parameters for optimal detection of cryopreserved antigen-specific responses for HIV vaccine trials","volume":"322","author":"Bull","year":"2007","journal-title":"J Immunol Methods"},{"issue":"March (5)","key":"10.1016\/j.vaccine.2014.08.022_bib0170","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1093\/infdis\/jis753","article-title":"Safety, immunogenicity, and surrogate markers of clinical efficacy for modified vaccinia Ankara as a smallpox vaccine in HIV-infected subjects","volume":"207","author":"Greenberg","year":"2013","journal-title":"J Infect Dis"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011359?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X14011359?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T08:24:26Z","timestamp":1538295866000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X14011359"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":32,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S0264410X14011359"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.022","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and immunogenicity of modified vaccinia Ankara as a smallpox vaccine in people with atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2014.08.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}